Dry age-related macular degeneration is the most common form of the disease, affecting millions of older Americans, according to the National Eye Institute. The condition develops ...

The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated ...

Eclipse Life Sciences, Inc., a privately held clinical-stage biopharmaceutical company focused on the development of novel therapies for ophthalmic diseases, today announced that it has completed ...

If you have dry age-related macular degeneration, your central vision may end up blurry, distorted or dim.

While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) focused on one condition or the other, retina specialists commonly encounter ...

Add Yahoo as a preferred source to see more of our stories on Google. USC Roski Eye Institute researchers are launching a phase 2b trial of a stem cell retinal implant designed to replace damaged ...

A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...

I have an elderly friend who’s becoming blind from macular degeneration. After hearing of a particularly frustrating event she experienced due to vision loss, I remembered the ...

Assessment of visual function by testing for visual acuity, dark adaptation, contrast sensitivity and evaluation of retinal sensitivity by microperimetry can indicate different stages of disease ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of a pivotal Phase 2b ...